ANXA3 and hepatocellular carcinoma: ANXA3 overexpression inhibits PKC/p38-mediated apoptosis and actives p38-mediated autophagy in sorafenib-resistant HepG2 and Huh7 HCC cells as well as in patient-derived xenografts